VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q59700142 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241221010724.0
008 241221nneanz||abbn n and d
035 ‎‡a (WKP)Q59700142‏
024 ‎‡a 0000-0002-8941-4116‏ ‎‡2 orcid‏
024 ‎‡a 55602764900‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q59700142‏
100 0 ‎‡a Jessica M Franklin‏ ‎‡c researcher‏ ‎‡9 en‏
375 ‎‡a 2‏ ‎‡2 iso5218‏
400 0 ‎‡a Jessica M Franklin‏ ‎‡c onderzoeker‏ ‎‡9 nl‏
670 ‎‡a Author's A concept-wide association study to identify potential risk factors for nonadherence among prevalent users of antihypertensives‏
670 ‎‡a Author's An evaluation of longitudinal changes in serum uric acid levels and associated risk of cardio-metabolic events and renal function decline in gout.‏
670 ‎‡a Author's Association Between Patient-Centered Medical Homes and Adherence to Chronic Disease Medications: A Cohort Study‏
670 ‎‡a Author's Association between trajectories of statin adherence and subsequent cardiovascular events‏
670 ‎‡a Author's Can purchasing information be used to predict adherence to cardiovascular medications? An analysis of linked retail pharmacy and insurance claims data‏
670 ‎‡a Author's Changing interactions between physician trainees and the pharmaceutical industry: a national survey.‏
670 ‎‡a Author's Claims data studies of direct oral anticoagulants can achieve balance in important clinical parameters only observable in electronic health records‏
670 ‎‡a Author's Comparing the performance of propensity score methods in healthcare database studies with rare outcomes.‏
670 ‎‡a Author's Did HEDIS get it right? Evaluating the quality of a quality measure: adherence to β-blockers and cardiovascular outcomes after myocardial infarction‏
670 ‎‡a Author's Distributions of industry payments to Massachusetts physicians.‏
670 ‎‡a Author's Do patients trust the FDA?: a survey assessing how patients view the generic drug approval process‏
670 ‎‡a Author's Effect of Reminder Devices on Medication Adherence: The REMIND Randomized Clinical Trial‏
670 ‎‡a Author's Effects of expanding the look-back period to all available data in the assessment of covariates.‏
670 ‎‡a Author's Eliminating medication copayments reduces disparities in cardiovascular care.‏
670 ‎‡a Author's Emulating Randomized Clinical Trials with Nonrandomized Real-World Evidence Studies: First Results from the RCT DUPLICATE Initiative‏
670 ‎‡a Author's Emulation Differences vs. Biases When Calibrating Real-World Evidence Findings Against Randomized Controlled Trials‏
670 ‎‡a Author's Equity in the receipt of oseltamivir in the United States during the H1N1 pandemic‏
670 ‎‡a Author's Evaluating Cardiovascular Health Disparities Using Estimated Race/Ethnicity: A Validation Study‏
670 ‎‡a Author's Evaluating possible confounding by prescriber in comparative effectiveness research‏
670 ‎‡a Author's Evaluating the Use of Nonrandomized Real-World Data Analyses for Regulatory Decision Making‏
670 ‎‡a Author's Generalized boosted modeling to identify subgroups where effect of dabigatran versus warfarin may differ: An observational cohort study of patients with atrial fibrillation‏
670 ‎‡a Author's Group-based trajectory models: a new approach to classifying and predicting long-term medication adherence.‏
670 ‎‡a Author's Longitudinal Patterns of Spending Enhance the Ability to Predict Costly Patients: A Novel Approach to Identify Patients for Cost Containment.‏
670 ‎‡a Author's Matching by propensity score in cohort studies with three treatment groups‏
670 ‎‡a Author's Nonrandomized Real-World Evidence to Support Regulatory Decision Making: Process for a Randomized Trial Replication Project‏
670 ‎‡a Author's Observing versus Predicting: Initial Patterns of Filling Predict Long-Term Adherence More Accurately Than High-Dimensional Modeling Techniques‏
670 ‎‡a Author's P-values and decision-making: discussion of 'Limitations of empirical calibration of p-values using observational data'.‏
670 ‎‡a Author's Persistent opioid use following cesarean delivery: patterns and predictors among opioid-naïve women‏
670 ‎‡a Author's Postoperative Inpatient Utilization of Opioid and Opioid-sparing Analgesics in the United States hospitals, 2007-2017‏
670 ‎‡a Author's Predicting 1-Year Statin Adherence Among Prevalent Users: A Retrospective Cohort Study‏
670 ‎‡a Author's Predicting Adherence to Chronic Disease Medications in Patients with Long-term Initial Medication Fills Using Indicators of Clinical Events and Health Behaviors.‏
670 ‎‡a Author's Predicting adherence trajectory using initial patterns of medication filling‏
670 ‎‡a Author's Prediction of rates of thromboembolic and major bleeding outcomes with dabigatran or warfarin among patients with atrial fibrillation: new initiator cohort study‏
670 ‎‡a Author's Rationale and design of the Randomized Evaluation to Measure Improvements in Non-adherence from Low-Cost Devices (REMIND) trial‏
670 ‎‡a Author's Regularized Regression Versus the High-Dimensional Propensity Score for Confounding Adjustment in Secondary Database Analyses‏
670 ‎‡a Author's Risk of venous thromboembolism in patients with rheumatoid arthritis: initiating disease-modifying antirheumatic drugs‏
670 ‎‡a Author's Sequential value-of-information assessment for prospective drug safety monitoring using claims databases: the comparative safety of prasugrel v. clopidogrel.‏
670 ‎‡a Author's The relative benefits of claims and electronic health record data for predicting medication adherence trajectory.‏
670 ‎‡a Author's The risk of congenital malformations associated with exposure to β-blockers early in pregnancy: a meta-analysis.‏
670 ‎‡a Author's Type of stress ulcer prophylaxis and risk of nosocomial pneumonia in cardiac surgical patients: cohort study‏
670 ‎‡a Author's Using Healthcare Databases to Replicate Trial Findings for Supplemental Indications: Adalimumab in Patients with Ulcerative Colitis‏
670 ‎‡a Author's Variable Selection for Confounding Adjustment in High-dimensional Covariate Spaces When Analyzing Healthcare Databases.‏
909 ‎‡a (scopus) 55602764900‏ ‎‡9 1‏
909 ‎‡a (orcid) 0000000289414116‏ ‎‡9 1‏
919 ‎‡a variableselectionforconfoundingadjustmentinhighdimensionalcovariatespaceswhenanalyzinghealthcaredatabases‏ ‎‡A Variable Selection for Confounding Adjustment in High-dimensional Covariate Spaces When Analyzing Healthcare Databases.‏ ‎‡9 1‏
919 ‎‡a usinghealthcaredatabasestoreplicatetrialfindingsforsupplementalindicationsadalimumabinpatientswithulcerativecolitis‏ ‎‡A Using Healthcare Databases to Replicate Trial Findings for Supplemental Indications: Adalimumab in Patients with Ulcerative Colitis‏ ‎‡9 1‏
919 ‎‡a typeofstressulcerprophylaxisandriskofnosocomialpneumoniaincardiacsurgicalpatientscohortstudy‏ ‎‡A Type of stress ulcer prophylaxis and risk of nosocomial pneumonia in cardiac surgical patients: cohort study‏ ‎‡9 1‏
919 ‎‡a riskofcongenitalmalformationsassociatedwithexposuretoβblockersearlyinpregnancyametaanalysis‏ ‎‡A The risk of congenital malformations associated with exposure to β-blockers early in pregnancy: a meta-analysis.‏ ‎‡9 1‏
919 ‎‡a relativebenefitsofclaimsandelectronichealthrecorddataforpredictingmedicationadherencetrajectory‏ ‎‡A The relative benefits of claims and electronic health record data for predicting medication adherence trajectory.‏ ‎‡9 1‏
919 ‎‡a sequentialvalueofinformationassessmentforprospectivedrugsafetymonitoringusingclaimsdatabasesthecomparativesafetyofprasugrel5clopidogrel‏ ‎‡A Sequential value-of-information assessment for prospective drug safety monitoring using claims databases: the comparative safety of prasugrel v. clopidogrel.‏ ‎‡9 1‏
919 ‎‡a riskofvenousthromboembolisminpatientswithrheumatoidarthritisinitiatingdiseasemodifyingantirheumaticdrugs‏ ‎‡A Risk of venous thromboembolism in patients with rheumatoid arthritis: initiating disease-modifying antirheumatic drugs‏ ‎‡9 1‏
919 ‎‡a regularizedregressionversusthehighdimensionalpropensityscoreforconfoundingadjustmentinsecondarydatabaseanalyses‏ ‎‡A Regularized Regression Versus the High-Dimensional Propensity Score for Confounding Adjustment in Secondary Database Analyses‏ ‎‡9 1‏
919 ‎‡a rationaleanddesignoftherandomizedevaluationtomeasureimprovementsinnonadherencefromlowcostdevicesremindtrial‏ ‎‡A Rationale and design of the Randomized Evaluation to Measure Improvements in Non-adherence from Low-Cost Devices (REMIND) trial‏ ‎‡9 1‏
919 ‎‡a predictionofratesofthromboembolicandmajorbleedingoutcomeswithdabigatranorwarfarinamongpatientswithatrialfibrillationnewinitiatorcohortstudy‏ ‎‡A Prediction of rates of thromboembolic and major bleeding outcomes with dabigatran or warfarin among patients with atrial fibrillation: new initiator cohort study‏ ‎‡9 1‏
919 ‎‡a predictingadherencetrajectoryusinginitialpatternsofmedicationfilling‏ ‎‡A Predicting adherence trajectory using initial patterns of medication filling‏ ‎‡9 1‏
919 ‎‡a predictingadherencetochronicdiseasemedicationsinpatientswithlongterminitialmedicationfillsusingindicatorsofclinicaleventsandhealthbehaviors‏ ‎‡A Predicting Adherence to Chronic Disease Medications in Patients with Long-term Initial Medication Fills Using Indicators of Clinical Events and Health Behaviors.‏ ‎‡9 1‏
919 ‎‡a predicting1yearstatinadherenceamongprevalentusersaretrospectivecohortstudy‏ ‎‡A Predicting 1-Year Statin Adherence Among Prevalent Users: A Retrospective Cohort Study‏ ‎‡9 1‏
919 ‎‡a postoperativeinpatientutilizationofopioidandopioidsparinganalgesicsintheunitedstateshospitals2007‏ ‎‡A Postoperative Inpatient Utilization of Opioid and Opioid-sparing Analgesics in the United States hospitals, 2007-2017‏ ‎‡9 1‏
919 ‎‡a persistentopioidusefollowingcesareandeliverypatternsandpredictorsamongopioidnaivewomen‏ ‎‡A Persistent opioid use following cesarean delivery: patterns and predictors among opioid-naïve women‏ ‎‡9 1‏
919 ‎‡a pvaluesanddecisionmakingdiscussionoflimitationsofempiricalcalibrationofpvaluesusingobservationaldata‏ ‎‡A P-values and decision-making: discussion of 'Limitations of empirical calibration of p-values using observational data'.‏ ‎‡9 1‏
919 ‎‡a observingversuspredictinginitialpatternsoffillingpredictlongtermadherencemoreaccuratelythanhighdimensionalmodelingtechniques‏ ‎‡A Observing versus Predicting: Initial Patterns of Filling Predict Long-Term Adherence More Accurately Than High-Dimensional Modeling Techniques‏ ‎‡9 1‏
919 ‎‡a nonrandomizedrealworldevidencetosupportregulatorydecisionmakingprocessforarandomizedtrialreplicationproject‏ ‎‡A Nonrandomized Real-World Evidence to Support Regulatory Decision Making: Process for a Randomized Trial Replication Project‏ ‎‡9 1‏
919 ‎‡a matchingbypropensityscoreincohortstudieswith3treatmentgroups‏ ‎‡A Matching by propensity score in cohort studies with three treatment groups‏ ‎‡9 1‏
919 ‎‡a longitudinalpatternsofspendingenhancetheabilitytopredictcostlypatientsanovelapproachtoidentifypatientsforcostcontainment‏ ‎‡A Longitudinal Patterns of Spending Enhance the Ability to Predict Costly Patients: A Novel Approach to Identify Patients for Cost Containment.‏ ‎‡9 1‏
919 ‎‡a groupbasedtrajectorymodelsanewapproachtoclassifyingandpredictinglongtermmedicationadherence‏ ‎‡A Group-based trajectory models: a new approach to classifying and predicting long-term medication adherence.‏ ‎‡9 1‏
919 ‎‡a generalizedboostedmodelingtoidentifysubgroupswhereeffectofdabigatranversuswarfarinmaydifferanobservationalcohortstudyofpatientswithatrialfibrillation‏ ‎‡A Generalized boosted modeling to identify subgroups where effect of dabigatran versus warfarin may differ: An observational cohort study of patients with atrial fibrillation‏ ‎‡9 1‏
919 ‎‡a evaluatingtheuseofnonrandomizedrealworlddataanalysesforregulatorydecisionmaking‏ ‎‡A Evaluating the Use of Nonrandomized Real-World Data Analyses for Regulatory Decision Making‏ ‎‡9 1‏
919 ‎‡a evaluatingpossibleconfoundingbyprescriberincomparativeeffectivenessresearch‏ ‎‡A Evaluating possible confounding by prescriber in comparative effectiveness research‏ ‎‡9 1‏
919 ‎‡a evaluatingcardiovascularhealthdisparitiesusingestimatedraceethnicityavalidationstudy‏ ‎‡A Evaluating Cardiovascular Health Disparities Using Estimated Race/Ethnicity: A Validation Study‏ ‎‡9 1‏
919 ‎‡a equityinthereceiptofoseltamivirintheunitedstatesduringtheh1n1pandemic‏ ‎‡A Equity in the receipt of oseltamivir in the United States during the H1N1 pandemic‏ ‎‡9 1‏
919 ‎‡a emulationdifferencesvsbiaseswhencalibratingrealworldevidencefindingsagainstrandomizedcontrolledtrials‏ ‎‡A Emulation Differences vs. Biases When Calibrating Real-World Evidence Findings Against Randomized Controlled Trials‏ ‎‡9 1‏
919 ‎‡a emulatingrandomizedclinicaltrialswithnonrandomizedrealworldevidencestudies1resultsfromtherctduplicateinitiative‏ ‎‡A Emulating Randomized Clinical Trials with Nonrandomized Real-World Evidence Studies: First Results from the RCT DUPLICATE Initiative‏ ‎‡9 1‏
919 ‎‡a eliminatingmedicationcopaymentsreducesdisparitiesincardiovascularcare‏ ‎‡A Eliminating medication copayments reduces disparities in cardiovascular care.‏ ‎‡9 1‏
919 ‎‡a effectsofexpandingthelookbackperiodtoallavailabledataintheassessmentofcovariates‏ ‎‡A Effects of expanding the look-back period to all available data in the assessment of covariates.‏ ‎‡9 1‏
919 ‎‡a effectofreminderdevicesonmedicationadherencetheremindrandomizedclinicaltrial‏ ‎‡A Effect of Reminder Devices on Medication Adherence: The REMIND Randomized Clinical Trial‏ ‎‡9 1‏
919 ‎‡a dopatientstrustthefdaasurveyassessinghowpatientsviewthegenericdrugapprovalprocess‏ ‎‡A Do patients trust the FDA?: a survey assessing how patients view the generic drug approval process‏ ‎‡9 1‏
919 ‎‡a distributionsofindustrypaymentstomassachusettsphysicians‏ ‎‡A Distributions of industry payments to Massachusetts physicians.‏ ‎‡9 1‏
919 ‎‡a didhedisgetitrightevaluatingthequalityofaqualitymeasureadherencetoβblockersandcardiovascularoutcomesaftermyocardialinfarction‏ ‎‡A Did HEDIS get it right? Evaluating the quality of a quality measure: adherence to β-blockers and cardiovascular outcomes after myocardial infarction‏ ‎‡9 1‏
919 ‎‡a comparingtheperformanceofpropensityscoremethodsinhealthcaredatabasestudieswithrareoutcomes‏ ‎‡A Comparing the performance of propensity score methods in healthcare database studies with rare outcomes.‏ ‎‡9 1‏
919 ‎‡a claimsdatastudiesofdirectoralanticoagulantscanachievebalanceinimportantclinicalparametersonlyobservableinelectronichealthrecords‏ ‎‡A Claims data studies of direct oral anticoagulants can achieve balance in important clinical parameters only observable in electronic health records‏ ‎‡9 1‏
919 ‎‡a changinginteractionsbetweenphysiciantraineesandthepharmaceuticalindustryanationalsurvey‏ ‎‡A Changing interactions between physician trainees and the pharmaceutical industry: a national survey.‏ ‎‡9 1‏
919 ‎‡a canpurchasinginformationbeusedtopredictadherencetocardiovascularmedicationsananalysisoflinkedretailpharmacyandinsuranceclaimsdata‏ ‎‡A Can purchasing information be used to predict adherence to cardiovascular medications? An analysis of linked retail pharmacy and insurance claims data‏ ‎‡9 1‏
919 ‎‡a associationbetweentrajectoriesofstatinadherenceandsubsequentcardiovascularevents‏ ‎‡A Association between trajectories of statin adherence and subsequent cardiovascular events‏ ‎‡9 1‏
919 ‎‡a associationbetweenpatientcenteredmedicalhomesandadherencetochronicdiseasemedicationsacohortstudy‏ ‎‡A Association Between Patient-Centered Medical Homes and Adherence to Chronic Disease Medications: A Cohort Study‏ ‎‡9 1‏
919 ‎‡a evaluationoflongitudinalchangesinserumuricacidlevelsandassociatedriskofcardiometaboliceventsandrenalfunctiondeclineingout‏ ‎‡A An evaluation of longitudinal changes in serum uric acid levels and associated risk of cardio-metabolic events and renal function decline in gout.‏ ‎‡9 1‏
919 ‎‡a conceptwideassociationstudytoidentifypotentialriskfactorsfornonadherenceamongprevalentusersofantihypertensives‏ ‎‡A A concept-wide association study to identify potential risk factors for nonadherence among prevalent users of antihypertensives‏ ‎‡9 1‏
943 ‎‡a 201x‏ ‎‡A 2017‏ ‎‡9 1‏
946 ‎‡a a‏ ‎‡9 1‏
996 ‎‡2 BIBSYS|90286464‏
996 ‎‡2 LC|nr 89011133‏
996 ‎‡2 LC|no2013118829‏
996 ‎‡2 LC|no2016084336‏
996 ‎‡2 LC|n 79134982‏
996 ‎‡2 DNB|10377131X‏
996 ‎‡2 ISNI|000000044533424X‏
996 ‎‡2 ISNI|0000000052749639‏
996 ‎‡2 NUKAT|n 2004255347‏
996 ‎‡2 ISNI|0000000079230036‏
996 ‎‡2 LC|nr 95014251‏
996 ‎‡2 LC|n 2023182827‏
996 ‎‡2 DNB|105288282X‏
996 ‎‡2 ISNI|0000000049321404‏
996 ‎‡2 NYNYRILM|326800‏
996 ‎‡2 ISNI|0000000020355643‏
996 ‎‡2 ISNI|0000000447092117‏
996 ‎‡2 LC|n 2015205106‏
996 ‎‡2 RERO|A022854778‏
996 ‎‡2 N6I|vtls001400381‏
996 ‎‡2 DNB|104259353‏
996 ‎‡2 LC|n 2010029042‏
996 ‎‡2 CAOONL|ncf10057724‏
996 ‎‡2 LC|n 81075164‏
996 ‎‡2 LC|n 2007020286‏
996 ‎‡2 ISNI|0000000066883935‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏